Total Payments
$10,003
2024 Payments
$1,122
Companies
37
Transactions
327
Medicare Patients
4,864
Medicare Billing
$160,405
Payment Breakdown by Category
Food & Beverage$8,229 (82.3%)
Travel$1,775 (17.7%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,229 | 322 | 82.3% |
| Travel and Lodging | $1,775 | 5 | 17.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| BIOTRONIK INC. | $3,129 | 22 | $0 (2020) |
| Medtronic Vascular, Inc. | $1,488 | 14 | $0 (2020) |
| Amgen Inc. | $781.90 | 60 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $742.20 | 48 | $0 (2024) |
| PFIZER INC. | $535.66 | 41 | $0 (2024) |
| Boston Scientific Corporation | $296.13 | 8 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $294.04 | 21 | $0 (2024) |
| Medtronic, Inc. | $290.93 | 6 | $0 (2023) |
| Sirtex Medical Inc | $268.42 | 6 | $0 (2023) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $235.71 | 11 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,122 | 62 | Novartis Pharmaceuticals Corporation ($358.26) |
| 2023 | $806.29 | 34 | Medtronic, Inc. ($168.30) |
| 2022 | $732.21 | 34 | Sirtex Medical Inc ($239.14) |
| 2021 | $594.42 | 23 | BOSTON SCIENTIFIC CORPORATION ($182.80) |
| 2020 | $217.08 | 5 | BIOTRONIK INC. ($124.97) |
| 2019 | $875.06 | 27 | Medtronic Vascular, Inc. ($233.18) |
| 2018 | $2,413 | 65 | Medtronic Vascular, Inc. ($896.94) |
| 2017 | $3,244 | 77 | BIOTRONIK INC. ($2,130) |
All Payment Transactions
327 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $16.19 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/16/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $20.05 | General |
| Category: Cardiology | ||||||
| 12/10/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $19.86 | General |
| Category: Cardiovascular | ||||||
| 12/05/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $11.07 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/03/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $17.76 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/22/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $24.24 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/14/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $19.78 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/14/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $8.58 | General |
| Category: Cardiology | ||||||
| 11/12/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $6.95 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/07/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $16.74 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/16/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $9.22 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/15/2024 | iRhythm Technologies, Inc. | ZIO XT Patch (Device), Zio monitor | Food and Beverage | In-kind items and services | $20.71 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/14/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $17.22 | General |
| Category: Cardiology | ||||||
| 10/09/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $16.16 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/08/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $18.97 | General |
| Category: NEUROLOGY | ||||||
| 10/08/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $18.25 | General |
| Category: Cardiology | ||||||
| 09/26/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $30.35 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 09/24/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $4.20 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/17/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $17.22 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/13/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $16.68 | General |
| Category: Cardiology | ||||||
| 09/04/2024 | Alnylam Pharmaceuticals Inc. | ONPATTRO (Drug) | Food and Beverage | In-kind items and services | $29.89 | General |
| Category: Genetic Disease | ||||||
| 09/03/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $18.31 | General |
| Category: Cardiology | ||||||
| 08/28/2024 | Baxter Healthcare | Hillrom - Carnation Ambulatory Monitor (Device) | Food and Beverage | In-kind items and services | $34.46 | General |
| Category: Cardiac Arrhythmia Monitoring | ||||||
| 08/27/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $17.44 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/26/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $14.66 | General |
| Category: Cardiology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 19 | 1,256 | 1,750 | $183,914 | $40,750 |
| 2022 | 17 | 1,235 | 1,679 | $136,798 | $39,382 |
| 2021 | 15 | 1,179 | 1,523 | $156,375 | $44,282 |
| 2020 | 16 | 1,194 | 1,600 | $136,054 | $35,991 |
Total Patients
4,864
Total Services
6,552
Medicare Billing
$160,405
Procedure Codes
74
All Medicare Procedures & Services
74 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 70 | 120 | $10,863 | $5,932 | 54.6% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 692 | 964 | $37,596 | $5,714 | 15.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 41 | 64 | $9,470 | $4,568 | 48.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 23 | 24 | $10,752 | $3,344 | 31.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 31 | 49 | $7,889 | $3,114 | 39.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 22 | 29 | $9,048 | $2,546 | 28.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 30 | 40 | $10,680 | $2,423 | 22.7% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 39 | 39 | $17,433 | $2,063 | 11.8% |
| 93454 | Insertion of tube in coronary artery for diagnosis with review by radiologist | Facility | 2023 | 15 | 15 | $28,590 | $1,932 | 6.8% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Facility | 2023 | 47 | 73 | $5,037 | $1,548 | 30.7% |
| 93295 | Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | Facility | 2023 | 33 | 56 | $5,544 | $1,517 | 27.4% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 25 | 25 | $6,575 | $1,338 | 20.4% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 12 | 12 | $3,648 | $1,258 | 34.5% |
| 93298 | Evaluation of cardiac rhythm monitor system, remote up to 30 days | Facility | 2023 | 22 | 64 | $3,776 | $1,237 | 32.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 34 | 54 | $4,104 | $502.92 | 12.3% |
| 93280 | Programming of dual lead pacemaker system | Facility | 2023 | 18 | 20 | $4,240 | $490.92 | 11.6% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2023 | 28 | 28 | $2,772 | $409.00 | 14.8% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 28 | 28 | $1,848 | $271.33 | 14.7% |
| 93244 | Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | Facility | 2023 | 11 | 11 | $572.00 | $204.93 | 35.8% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 18 | 18 | $1,998 | $178.53 | 8.9% |
| 93356 | Heart muscle strain imaging | Facility | 2023 | 17 | 17 | $1,479 | $157.93 | 10.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 100 | 159 | $12,879 | $7,880 | 61.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 59 | 80 | $11,280 | $5,946 | 52.7% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2022 | 681 | 901 | $33,337 | $5,604 | 16.8% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 21 | 21 | $8,946 | $3,201 | 35.8% |
About Dr. Leslie Levenson, MD
Dr. Leslie Levenson, MD is a Cardiovascular Disease healthcare provider based in Marrero, Louisiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/26/2006. The National Provider Identifier (NPI) number assigned to this provider is 1689630717.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Leslie Levenson, MD has received a total of $10,003 in payments from pharmaceutical and medical device companies, with $1,122 received in 2024. These payments were reported across 327 transactions from 37 companies. The most common payment nature is "Food and Beverage" ($8,229).
As a Medicare-enrolled provider, Levenson has provided services to 4,864 Medicare beneficiaries, totaling 6,552 services with total Medicare billing of $160,405. Data is available for 4 years (2020–2023), covering 74 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Interventional Cardiology
- Location Marrero, LA
- Active Since 04/26/2006
- Last Updated 03/05/2015
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1689630717
Products in Payments
- Micra (Device) $852.19
- Repatha (Biological) $541.33
- ELIQUIS (Drug) $525.20
- ENTRESTO (Drug) $426.43
- LEQVIO (Drug) $304.16
- XARELTO (Drug) $294.04
- Resolute (Device) $271.07
- SIR-Spheres Microspheres (Device) $268.42
- Corlanor (Drug) $240.57
- LifeVest (Device) $235.71
- RESOLUTE ONYX (Device) $201.38
- ONPATTRO (Drug) $153.65
- CHANTIX (Drug) $152.88
- LUX DX (Device) $146.02
- CoreValve Evolut (Device) $135.64
- Reveal LINQ (Device) $128.13
- Edwards SAPIEN 3 Transcatheter Heart Valve (Device) $126.85
- Livalo (Drug) $116.03
- Assure WCD (Device) $108.87
- Trilogy 100 (Device) $103.66
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Marrero
Dr. Frederick Kushner, Md, MD
Cardiovascular Disease — Payments: $85,845
Cardiovascular Disease $85,845
Dr. Carlos Rodriguez Fierro, M.d, M.D
Cardiovascular Disease — Payments: $18,027
Cardiovascular Disease $18,027
Dr. Robert Matheney, Md, MD
Cardiovascular Disease — Payments: $12,679
Cardiovascular Disease $12,679
Dr. Edmund Kerut, Md, MD
Cardiovascular Disease — Payments: $8,615
Cardiovascular Disease $8,615
Stephen Laguardia, Md, MD
Cardiovascular Disease — Payments: $7,756
Cardiovascular Disease $7,756
Dr. Brian Cospolich, Md, MD
Cardiovascular Disease — Payments: $7,654
Cardiovascular Disease $7,654